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Japanese encephalitis virus (JEV) is a mosquito–borne agent that can cause 
encephalitis in equids and humans and reproductive disease in pigs. Rare clinical 
cases have also been reported in other species, such as cattle. Japanese encephalitis 
can be a very serious disease in people: although most infections are asymptomatic, 
clinical cases tend to manifest as severe encephalitis, and many survivors are left with 
neurological sequelae. All ages can be affected in a population without previous 
exposure; however, Japanese encephalitis tends to be a childhood disease in endemic 
areas, where most people develop immunity by the time they reach adulthood. 
Morbidity and mortality can be high in unvaccinated populations during epidemics. 
Approximately 4,000 people died during the 1924 epidemic in Japan, and nearly 2500 
fatalities occurred in South Korea in 1949. Likewise, more than 3700 equids died 
during an epidemic in Japan in 1949.  
Japanese encephalitis virus has gradually expanded its geographic range within 
Asia and spread to parts of the western Pacific region during the last 50 years. It could 
become endemic in additional regions, similarly to West Nile virus, which became 
established in the Americas in the 1990s. Eradication is unlikely once JEV enters 
mosquito populations, as the virus is maintained and amplified in cycles between 
these vectors and various vertebrate hosts such as pigs and wild birds. Vaccination 
has reduced the number of clinical cases among horses in endemic areas, and is 
mandatory in certain animals (e.g., racehorses) in some countries. Childhood 
vaccination has, likewise, greatly decreased the number of human cases in some 
nations; however, vaccination rates vary, and this disease is still very common in 
some areas. Some regions have recently reported a relative increase in the percentage 
of cases seen in adults, leading to suggestions that vaccination campaigns also be 
conducted in this group.  
Etiology 
Japanese encephalitis virus (JEV) is an arbovirus (arthropod-transmitted virus) in 
the genus Flavivirus and family Flaviviridae. There is only one serotype of JEV, but 
at least five genotypes. Some genotypes are more common than others, and the 
dominant genotypes in an area can change over time. For example, genotype I has 
become common in some areas where genotype III used to be prevalent.  
Japanese encephalitis virus is closely related to St. Louis encephalitis virus, 
Murray Valley encephalitis virus and West Nile virus; these viruses and a few others 
comprise the Japanese encephalitis serogroup of the flaviviruses.  
Species Affected 
Illnesses caused by JEV occur mainly in equids (e.g., horses, donkeys) and pigs; 
however, rare clinical cases have been reported in cows, and other species may be 
susceptible. Asymptomatic infections have been documented in many other 
domesticated and wild mammals (e.g., cattle, sheep, goats, rabbits, dogs, cats, wild 
boar, raccoons) and birds, as well as in reptiles and amphibians. Reports of infections 
in some species may be based on serology alone. 
Ardeid birds (herons and egrets) and suids (domesticated and wild pigs) develop 
viremia sufficient to infect mosquitoes, and are considered to be important in 
maintaining and amplifying JEV. Other birds (e.g., young poultry, swallows) have 
also been suggested as possible reservoirs, and many avian species have never been 
examined for their ability to maintain or amplify this virus. There are also reports 
suggesting that bats might be significant in some cycles. An early study suggested 
that wild rodents are not important maintenance hosts.  
Zoonotic potential 
Humans are susceptible to Japanese encephalitis. 
Geographic Distribution 
Japanese encephalitis is widespread in temperate and tropical regions of Asia, 
and also occurs in parts of the western Pacific. Its precise distribution in some areas is 
unclear, due to limited surveillance and/or cross-reactivity with other flaviviruses in  
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serological tests. In Australia, the virus is endemic on the 
Torres Strait islands, and there have been reports of it on 
the northern mainland, but it may not be established in the 
latter location. There are also rare reports describing 
possible JEV in mosquitoes and birds in southern Europe. 
Specifically, a portion of the JEV genome was identified in 
dead birds in Italy in 2000, and JEV gene segments were 
detected by PCR in mosquitoes in Italy in 2010. However, 
the evidence to date is not definitive, and the presence of 
circulating live virus remains to be confirmed.  
Transmission 
Japanese encephalitis virus is usually transmitted by 
mosquitoes in the genus Culex. The specific mosquito 
vectors vary with the region; however, Culex 
tritaeniorhynchus is important in spreading this virus to 
humans and domesticated animals across a wide geographic 
range. C. tritaeniorhynchus breeds in rice paddies and 
connecting canals, and is active at twilight. Other culicine 
species can also be important locally and/or as minor 
vectors. For example, members of the C. sitiens subgroup, 
especially C. annulirostris, are the most important vectors 
in Australia. JEV has been reported in other genera of 
mosquitoes, and it was isolated from Culicoides midges in 
China, but the significance of these vectors is unclear. 
JEV is usually transmitted in mosquito bites, although 
lizards and bats can also become infected by eating infected 
mosquitoes. Humans and most domesticated animals are 
incidental hosts, with low viremia, and are not considered 
to be important in virus transmission. For example, while 
horse-to-horse transmission via mosquitoes has been 
demonstrated in the laboratory, viremia is low and there are 
usually too few susceptible horses nearby to maintain the 
virus. Although both birds and suids can amplify JEV, 
domesticated pigs are considered to be particularly good 
amplifying hosts, as large numbers of susceptible young 
swine are produced each year, sometimes in close 
proximity to people. Boars are reported to transmit the virus 
in semen. 
In addition to mosquito bites, infections in people 
have been reported after exposure to JEV in the laboratory 
or during tissue sample collection. This virus can be 
transmitted through mucous membranes or broken skin, 
inhaled in aerosols, or acquired by needlestick injuries.  
Japanese encephalitis virus does not survive well 
outside a living host. How the virus persists during the 
winter in temperate climates is uncertain, although various 
mechanisms have been suggested.  
Disinfection 
Agents reported to be effective for JEV disinfection 
include 70% ethanol, 2% glutaraldehyde, 3–8% 
formaldehyde, 1% sodium hypochlorite, iodine, phenol 
iodophors and organic solvents/detergents. This virus is 
also sensitive to heat, ultraviolet light and gamma 
irradiation.  
Infections in Animals 
Incubation Period 
The incubation period in experimentally infected 
horses is 4 to 14 days. Experimentally infected pigs can 
develop clinical signs after 3 days (with rising temperature 
detected in some animals as early as 24 hours after 
inoculation). 
Clinical Signs 
Most infections in horses are subclinical, and 
symptomatic cases vary in severity. Some horses have a 
mild illness with nonspecific signs such as a transient fever, 
anorexia, lethargy, and congested or jaundiced mucous 
membranes. This syndrome usually lasts for 2-3 days, and 
the horse recovers without complications. Other horses 
develop encephalitis. In the milder form, the animal is 
lethargic and anorexic, with a fluctuating fever and 
neurological signs that commonly include difficulty 
swallowing, incoordination, transient neck rigidity, radial 
paralysis or impaired vision. Signs of jaundice or petechial 
hemorrhages may be found on the mucous membranes. 
These horses often recover within a week. A more severe 
but uncommon form, called the “hyperexcitable form,” is 
characterized by high fever, aimless wandering, violent and 
demented behavior, profuse sweating, muscle tremors and 
occasionally blindness. Although some horses with this 
form recover, many collapse and die in 1-2 days. 
Neurological defects such as ataxia may persist in some 
animals after recovery. 
Naive pigs may have reproductive signs. The most 
common syndrome in this species is the birth of stillborn or 
mummified fetuses, usually at term. Infected piglets born 
alive often have tremors and convulsions, and die soon after 
birth. Pregnant sows may also abort. Nonpregnant pigs 
usually remain asymptomatic or experience a transient 
febrile illness, but signs of encephalitis are occasionally 
seen in pigs up to six months of age. A wasting syndrome 
was reported in one group of piglets with post-mortem 
evidence of nonsuppurative meningoencephalitis. In 
addition, disturbances of spermatogenesis can cause 
infertility in boars. Although this is usually temporary, it 
can be permanent in severely affected animals. 
Other domesticated animals can be infected but 
typically remain asymptomatic. Rare cases of Japanese 
encephalitis in cattle were characterized by neurological 
signs, sometimes preceded by nonspecific signs (e.g., 
fever, depression, decreased appetite). Some of these 
cases were fatal; other animals were euthanized. Three 
experimentally infected dogs did not develop clinical 
signs, and the authors of this study reported that no 
clinical cases have been seen among dogs in Japan, even 
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Post Mortem Lesions      Click to view images 
Only nonspecific lesions are seen in horses, and there are 
no characteristic gross lesions in the brain. Diffuse 
nonsuppurative encephalomyelitis is the characteristic 
microscopic lesion. Nonsuppurative encephalitis was also 
reported in the few cattle reported to have Japanese 
encephalitis, but the macroscopic lesions varied. One animal 
had no gross lesions in the brain, spinal cord or other organs. 
In two other cases, hemorrhages and/or congestion were 
found in the brain. Additional lesions with uncertain 
relevance to Japanese encephalitis were reported in some 
cases, and included pulmonary emphysema in two cattle.  
Mummified or stillborn fetuses can be found in litters 
from infected sows. Congenital neurological defects 
including hydrocephalus, cerebellar hypoplasia and spinal 
hypomyelinogenesis may be seen in some litters. 
Experimentally infected piglets with encephalitis had 
swelling and edema of the brain.  
Diagnostic Tests 
A definitive diagnosis of Japanese encephalitis can be 
made by virus isolation. Isolating JEV from infected horses 
can be difficult, even from tissues collected at necropsy; 
however, it may be attempted from brain samples (e.g., 
corpus striatum, cortex or thalamus) and the spinal cord. 
Tissue samples should be very fresh, i.e., taken from animals 
that have been dead for less than 12 hours, or from animals 
killed during the acute stage of the disease. It may also be 
possible to isolate this virus from the blood, serum or CSF of 
living horses, but viremia is usually short-lived and this is 
rarely successful. In swine, JEV may be isolated from the 
brains of affected fetuses or piglets with encephalitis. The 
sow has usually cleared the virus by the time an affected litter 
is born. Various cell lines are suitable for virus isolation; 
some culture systems that have been used include chicken 
embryo, baby hamster kidney (BHK) cells, African green 
monkey kidney (Vero) cells, the MDBK cell line and 
mosquito cell lines (e.g. C3/36). Mouse inoculation is also 
used during virus isolation. JEV can be recognized as a 
flavivirus by hemagglutination inhibition or enzyme-linked 
immunosorbent assays (ELISAs), and its identity can be 
confirmed by virus neutralization, reverse transcription 
polymerase chain reaction (RT-PCR) assays, or immuno-
fluorescence to detect viral antigens.  
JEV can also be detected directly in tissues or blood by 
RT-PCR; however, there is little published information on 
the use of this technique with clinical samples. Immuno-
histochemistry has been used to identify viral antigens in the 
central nervous system (CNS). Histopathology is also 
helpful. 
Serology is often used to diagnose Japanese encephalitis 
in endemic regions. Serological diagnosis can be complicated 
by pre-existing antibodies from vaccination or previous 
exposure to JEV, or cross-reactive antibodies to other viruses 
in the Japanese encephalitis serogroup. Tests that may be 
available include virus neutralization (e.g., the plaque 
neutralization test), hemagglutination inhibition, ELISAs to 
detect IgM (IgM capture ELISA) or IgG, and less commonly 
used assays such as complement fixation. Virus 
neutralization is the most specific assay, and has low cross-
reactivity, but its availability may be limited. In endemic 
regions, a definitive serological diagnosis usually depends on 
a significant rise in titer with paired acute and convalescent 
samples. Sows usually seroconvert before the onset of 
reproductive signs, and rising titers may not be observed in 
these animals. A presumptive diagnosis may be made if a 
high titer is found in a single serum sample and supportive 
evidence suggests Japanese encephalitis. In horses, the 
detection of specific IgM and IgG in cerebrospinal fluid 
(CSF) is also good evidence of infection.  
Treatment 
There is no specific antiviral therapy for Japanese 
encephalitis. Affected animals are treated symptomatically. 
Infected animals may be euthanized in regions where this 
disease is not endemic. 
Control 
Disease reporting 
Veterinarians who encounter or suspect a Japanese 
virus infection should follow their national and/or local 
guidelines for disease reporting. In the U.S., state or 
federal authorities must be notified immediately. 
Prevention 
Japanese encephalitis vaccines can prevent disease in 
horses and pigs in endemic areas. Sows are widely 
vaccinated for Japanese encephalitis in some countries, but 
not in others. Maternal antibodies may interfere with 
vaccination during the short lifespan of young pigs. 
Although vaccines are cross-protective between viral 
genotypes, some reports suggest their relative efficacy 
might differ. Past vaccines generally contained genotype III 
viruses, but new genotype I vaccines are being developed in 
some areas where these viruses have become common, and 
may soon be commercially available. Various measures to 
reduce contact with mosquitoes, such as stabling animals in 
screened barns during peak mosquito biting activity, can be 
partially protective, particularly during outbreaks. 
Insecticide-treated mosquito nets have sometimes been used 
to help protect pigs. Environmental control of mosquitoes 
may temporarily help control these vectors during an 
outbreak, but large-scale use of insecticides is costly, 
difficult to implement well long-term, may have adverse 
effects on the environment, and is impractical in many 
areas.  
Some control measures in swine are intended to help 
reduce the risk to other species. For example, pigs are 
sometimes relocated away from human population centers. 
Because JEV is also maintained in birds, some transmission 
can be expected to continue even if virus amplification in 
pigs can be controlled. 
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Morbidity and Mortality 
Japanese encephalitis may be a seasonal disease in 
endemic areas, depending on factors such as climate and 
rainfall patterns. In temperate regions, it may peak among 
horses in late summer and autumn when the virus spills 
over after being amplified in pigs and other animals. JEV 
circulates year-round in tropical areas, but there may be 
seasonal peaks of disease associated with irrigation, rainfall 
or other factors that affect the local abundance of 
mosquitoes and vertebrate amplifying hosts. In some areas, 
epidemics are associated with the rainy season. 
In horses, cases usually occur sporadically or in small 
clusters, but epidemics may be seen when there are large 
numbers of susceptible animals. Inapparent infections are 
common in this species. Between 1948 and 1967, the 
morbidity rate in Asia was estimated to be approximately 
0.045% (45 cases per 100,000 horses), but higher morbidity 
rates were reported during some outbreaks. During the 1948 
epizootic in Japan, the morbidity rate in horses was 0.3% 
overall, and as high as 1.4% in some areas. The case fatality 
rate in horses is reported to be approximately 5% or less in 
some areas, and 5-15% in others. Case fatality rates as high 
as 30-40% have been reported in some outbreaks. For 
example, when one group of susceptible broodmares was 
introduced to an endemic area, a third of the mares died. 
Vaccination has reduced the incidence of clinical cases 
among horses in endemic regions. 
Naïve pigs are reported to be highly susceptible to 
infection, with pregnant sows often aborting or giving birth 
to stillborn and mummified fetuses. During one epidemic in 
Japan, 50-70% of all pigs suffered reproductive losses. 
Affected piglets born alive often die; however, the mortality 
rate is close to zero in adult pigs. Japanese encephalitis may 
have much less impact on pigs in endemic regions, where 
they can develop immunity by the time they are bred. In 
one recent study, the only effects on reproductive 
performance occurred in young sows (i.e., animals <1.5 
years of age), and there was no impact when sows of all 
ages were analyzed. The number of swine in a region may 
affect the incidence of disease in other species, due to virus 
amplification in these animals. However, this varies with 
the type of husbandry practices, and modern pig farming 
does not necessarily increase the risk of infection. Where 
Japanese encephalitis is seasonal, serological surveillance 
in pigs can be used to help predict epidemics in humans. 
Some researchers have also suggested using serology in 
dogs, which are infected asymptomatically, to help predict 
human risk. 
Infections in Humans 
Incubation Period 
The incubation period in humans is estimated to be 5 to 
15 days. 
Clinical Signs 
The initial signs of Japanese encephalitis are usually 
nonspecific; they may include fever, chills, muscle aches 
and severe headache with vomiting. Children may appear to 
have a gastrointestinal illness, with nausea, vomiting and 
abdominal pain. Coryza and diarrhea are also mentioned by 
some authors. Some people recover after this stage, but 
others develop neurological signs. Signs suggestive of 
benign aseptic meningitis occur in a minority of the latter 
group, but most patients with neurological signs have 
encephalitis. Signs of encephalitis may develop gradually 
after the initial, nonspecific illness, or as a sudden onset of 
fever and convulsions. They may include a reduced level of 
consciousness, which can progress to coma; focal 
neurological signs; quadriplegia, hemiplegia or cerebellar 
disorders; and behavioral changes. Painful stiffness of the 
neck, and mild to severe convulsions, ranging from subtle 
focal signs to generalized seizures, are common. Movement 
disorders also occur frequently, and some people develop 
transient Parkinson’s like signs (e.g., masking of the face, 
paucity of blinking, rigidity with or without tremor, 
akinesia). Various atypical presentations have been 
reported, and include isolated acute onset behavioral 
abnormalities that may be misdiagnosed as psychiatric 
illnesses. Occasionally patients can develop flaccid 
paralysis resembling polio; some of these patients may not 
have signs of encephalitis. Some case series also describe 
syndromes in other organs, such as pulmonary edema and 
upper gastrointestinal hemorrhage. 
Convalescence can be prolonged, although some 
patients make a rapid, spontaneous recovery (“abortive 
encephalitis”). Up to 50% of the survivors have 
neurological sequelae such as epileptic seizures, a 
Parkinsonian syndrome with tremors and rigidity, or 
cognitive, behavioral or language impairment. Some 
survivors gradually improve, although this can take months 
or years. Miscarriages have been seen in pregnant women 
who were infected for the first time during pregnancy; 
however, this is reported to be uncommon in endemic areas.  
Diagnostic Tests 
Serology is often used to diagnose Japanese 
encephalitis in endemic areas, typically by detecting IgM in 
acute phase serum and CSF with an ELISA. Some studies 
have reported that a few patients were seronegative in 
serum, CSF or both. Asymptomatic infections or 
vaccination usually result in the presence of IgM in the 
serum but not CSF. Cross-reactivity with other flaviviruses 
is an issue in some serological assays such as ELISAs and 
hemagglutination inhibition. Virus neutralization tests can 
also be used, and a fourfold rise in neutralizing antibody 
titer is diagnostic in retrospective cases.  
Viremia in humans is usually transient and low level, 
and direct detection of viruses in the blood by virus 
isolation and/or RT-PCR is reported to be difficult. RT-
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PCR may also detect viral RNA in the CSF; however, this 
method does not appear to be commonly employed. 
Neuroimaging and electroencephalographic analysis 
can also be helpful, although they are not definitive. 
Treatment 
Treatment is supportive. There are currently no specific 
antiviral therapies for this disease. 
Control 
Several vaccines are available for humans. Japanese 
encephalitis vaccines are cross-protective against all viral 
genotypes; however, there are reports that immunity against 
genotypes other than the vaccine strain may be weaker. 
Childhood vaccination is routine in some countries. With a 
relative increase in adult cases, some areas are also 
considering or conducting vaccination campaigns in adults. 
In non-endemic areas, vaccines are primarily given to 
laboratory workers at risk of infection and travelers to 
endemic region. Recommendations for the latter group 
vary, depending on factors such as the season, duration of 
travel, activities and lodging.  
Other temporary preventive measures include the use 
of insect repellents, insecticide-impregnated bed nets, and 
long-sleeved shirts and pants to discourage mosquito bites. 
Environmental modifications to decrease mosquito 
populations (e.g., intermittent irrigation of rice fields, 
larvivorous fish, insecticide spraying) may be used in some 
areas or situations. Approaches to reduce amplification in 
pigs, as described above (Infections in Animals), have also 
been suggested or implemented. 
Morbidity and Mortality 
Japanese encephalitis is an important cause of illness, 
death and disability in parts of Asia. Vaccination, changes 
in agricultural practices, improved standards of living and 
other factors have greatly reduced the incidence of this 
disease in some countries; however, it continues to be 
widespread in others. More than 27,000 cases were reported 
to the World Health Organization (WHO) between 2006 
and 2009, and one recent analysis estimated the true 
worldwide incidence to be approximately 68,000 cases per 
year. As in animals, the patterns of disease in endemic 
regions vary with factors such as climate and rainfall. 
Human illnesses, like those in horses, may peak in late 
summer and autumn in some temperate regions, but can 
occur year-round in the tropics, with seasonal peaks caused 
by local factors such as rainfall.  
The risk of developing encephalitis is affected by many 
factors including the person’s age and immunity to 
flaviviruses. All ages can be affected in a population 
without previous exposure; however, clinical cases mainly 
occur in children (< 15 years) in endemic regions, where 
people usually develop immunity by the time they reach 
adulthood. An increasing proportion of cases have been 
reported in adults in some areas where children are 
vaccinated. The risk of infection also tends to be higher in 
rural areas than cities. Most human infections are 
asymptomatic: studies from endemic regions estimate that 
approximately one in every 100 to 1,000 infected people 
develops clinical signs. During some outbreaks (e.g., in 
people from nonendemic regions), this ratio can be as high 
as 1 in 25. The risk to all travelers visiting endemic regions 
has been estimated to be < 1 case per 1 million; however, 
the specific risk varies with the season, duration of travel, 
activities and lodgings. While most cases occur in people 
who visit an endemic area for a longer time, clinical cases 
have also occurred in short-term travelers. 
In symptomatic cases, reported case fatality rates range 
from < 5% to 40% and are occasionally higher. Some 
countries have reported that case fatality rates as well as 
morbidity rates have decreased significantly in recent years, 
possibly due to partial immunity from an incomplete 
vaccination series, better care and/or other factors. Up to 
30-50% of survivors have mild to severe neurological 
sequelae. Some of these people gradually improve, 
although this can take months or years. 
Internet Resources 
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